Adeshwar Meditex Ltd.
Snapshot View

16.75 -0.05 ▼-0.3%

29 March 2023, 04:01:00 PM
Volume: 6,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.adeshwarmeditex.com
Market Cap 24.17 Cr.
Enterprise Value(EV) 41.32 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.55 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 30.49 Trailing Twelve Months Ending 2022-03
Industry PE 32.00 Trailing Twelve Months Ending 2022-03
Book Value / Share 21.45 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.78 Calculated using Price: 16.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.44 Cr. 14,431,426 Shares
FaceValue 10
Company Profile
The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.30%
1 Week
-1.47%
1 Month
-29.32%
3 Month
-40.18%
6 Month
-34.31%
1 Year
-37.15%
2 Year
5 Year
10 Year
9 years 2012-03 2013-03 2014-03 2015-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 41.04 32.99 11.31 18.17 26.33 15.34 12.19 8.50 3.08
Return on Capital Employed (%) 32.84 29.48 15.72 16.75 28.76 17.59 14.29 11.13 6.98
Return on Assets (%) 6.66 8.93 3.83 6.58 10.52 5.89 4.30 2.87 1.18

Balance Sheet View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1 3 5 6 6 14 16 19 21 31
Non Curr. Liab. 1 2 3 3 3 1 6 7 6 4
Curr. Liab. 9 8 7 7 7 18 22 29 36 37
Minority Int.
Equity & Liab. 11 12 15 15 16 33 44 55 62 72
Non Curr. Assets 3 3 3 3 3 4 4 5 5 7
Curr. Assets 8 9 11 12 13 29 39 50 57 65
Misc. Exp. not W/O
Total Assets 11 12 15 15 16 33 44 55 62 72

Profit Loss View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 10 14 27 16 25 59 53 56 66 65
Other Income 0 0 0 0 0 2 0 0 0
Total Income 10 14 27 16 26 59 55 56 66 65
Total Expenditure -9 -12 -24 -14 -23 -53 -49 -51 -61 -61
PBIDT 1 2 3 2 2 6 6 6 5 4
Interest 0 0 -1 -1 -2 -2 -3 -2 -2
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 -1 0 0 -1 -1 -1 -1 0
Exceptional Items
PAT 0 1 1 1 1 3 2 2 2 1
Adjusted EPS 55 2 2 1 2 3 2 4 2 1

Cash Flow View Details >>

Particulars 7 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 -6 -1 3 -2
Cash Fr. Inv. 0 0 2 -1 -1
Cash Fr. Finan. 1 6 0 -3 4
Net Change 0 0 1 -1 1
Cash & Cash Eqvt 1 1 2 1 2

Shareholding Pattern View Details >>

6 Qtrs 2013-03 (%) 2013-09 (%) 2014-09 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%)
Promoter 0.00 0.00 0.00 42.65 42.65 42.65
Public 100.00 100.00 100.00 57.35 57.35 57.35
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 13 Mar 2023
Board Meeting Outcome for Re-Submission Of Outcome Of Board Meeting Held On 27Th February 2023
With reference to the e-mail received from BSE Ltd dated February 28 2022 in regards to Re-Submission of Outcome of Board Meeting held on 27th February 2023 we wish to re-submit the same with additional documents as required under Regulation 30 of SEBI (LODR) Regulations 2015.
Mon, 27 Feb 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday February 27 2023.
1. Taken a note of cessation of Mr. Siddharth Mulchand Talati Managing Director of the Company due to demise on Saturday 11 February 2023;2. Taken a note of the resignation tendered by Mr. Shailesh Vinayak Rajpure with effect from January 30 2023 due to pre-occupation;3. Considered and approved the appointment of Mr. Shailesh Vinayak Rajpure (DIN: 06758460) as an Additional Director (Executive) of the Company on the request of the Board;4. Authorized Mr. Shailesh Vinayak Rajpure (DIN: 06758460) Additional Director of the Company for various purposes;5. Authorised Ms. Shivani Tiwari Company Secretary Mr. Shailesh Rajpure Director for filing of various forms of the company;6. Considered surrendering of HDFC Life Sampoorn Samridhi Policy held in the name of Ms. Sitanshi Parikh maintained with HDFC Standard Life Insurance Company Limited with immediate effect.
Mon, 13 Feb 2023
Announcement under Regulation 30 (LODR)-Demise
In compliance of regulation 30 and 31A(6)(c) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we regret to inform about the sad demise of Shri Siddharth Mulchand Talati Managing Director and Promoter of the Company on Saturday February 11 2023.Further it is hereby informed that he would cease to be Promoter of the Company in accordance with Regulation 31A(6)(c) of the SEBI LODR Regulations 2015.The new promoter post the demise of Shri Siddharth Mulchand Talati will be his wife Smt Sucheta Siddharth Talati.

Technical Scans View Details >>

Mon, 27 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,473.23 2,818.70 +0.5%
Cipla Ltd. 71,800.08 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,031.17 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.21 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Adeshwar Meditex Ltd.

What is Adeshwar Meditex share price?

Can I buy Adeshwar Meditex shares now?

What is the Market Cap of Adeshwar Meditex?

What are the key metrics to analyse Adeshwar Meditex?

What is the 52 Week High and Low of Adeshwar Meditex?

What is the trend of Adeshwar Meditex share price?